Navigation Links
ALCAT Pioneer, Roger Deutsch, to Address "Food Allergies and Intolerances" at the Institute of Functional Medicine Conference in Tampa, February 8-10
Date:2/6/2013

DEERFIELD BEACH, Fla., Feb. 6, 2013 /PRNewswire/ -- Roger Deutsch, CEO of Cell Science Systems and pioneer of the ALCAT blood test, will be addressing the acclaimed Institute of Functional Medicine in Tampa Bay on Friday, February 8th.  The title of his presentation will be "Alternative Pathways in Life and Medicine".

The conference will be held at the Grand Hyatt Tampa Bay February 8-10th and the main topic will deal with Immunity and how dietary changes, lifestyle modifications, and nutraceutical, pharmaceutical, and botanical treatments can benefit the 23 million Americans sufferers of autoimmune diseases.

"I'm honored to attend such a prestigious event as many of the world's experts gather to discuss how environmental factors are playing a significant role in autoimmune diseases," said Roger Deutsch , CEO of Cell Science Systems and pioneer of the ALCAT blood test.  "I will specifically address in my presentation how food allergies and intolerances relate to autoimmune diseases."

ALCAT Worldwide is a division of Cell Science Systems, where the ALCAT Test is performed in its impressive licensed and FDA compliant laboratory.  The ALCAT Test is a simple blood test that measures the body's cellular response to a wide array of substances including foods, functional foods, medicinal herbs, food additives, food colorings, environmental chemicals, molds, pharmacoactive agents, and antibiotics.  The ALCAT Test identifies the personal triggers of inflammation caused by foods and chemicals.

The main objective of The Institute for Functional Medicine is to reverse today's epidemic of chronic disease through education, research, and collaboration. www.functionalmedicine.org

Cell Science Systems, Corp. (CSS), located in Deerfield Beach, Florida'/>"/>

SOURCE Cell Science Systems, Corp.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Imaging Contract-Research Pioneer, Donald P. Rosen, MD, Named CEO of ACR Image Metrix™
2. Genomatica, Inc., Award-Winning Industrial Biotechnology Pioneer, Selects Alexandria Real Estate Equities, Inc. for Long-Term, Mission-Critical R&D Facility and Corporate Headquarters
3. The Law Office of Roger G. Worthington, P.C. - Longtime Supporter of the Pacific Meso Center - Donates $100,000 for Mesothelioma Research
4. Members of Congress, Cancer Experts Address Impact of Genetic Testing on Cancer
5. Unigenes 2011 Year in Review - Key Elements in Place to Address Debt in 2012
6. Music Legend And Health Advocate Bret Michaels To Address Diversity Alliance For Science 2012 National Conference And EXPO
7. CEM President and CEO Delivers Commencement Address at the 2012 University of Texas at Austin Chemistry and Biochemistry Department Graduation
8. Biodetection 2012 Conference Brings Together Leading Organizations from Around the World to Address Challenges & Technology Advances in Detection and Identification of Biological Threats in Washington, DC from June 28-29, 2012
9. Specialty Chemical Forum 2012 Kicks Off in Houston; AkzoNobels Frank Sherman Delivers Keynote Address
10. Sequenom Addresses Preliminary Injunction Decision, Reaffirms Defense of Patent
11. Addressing the need for microscopic speed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... TEL-AVIV, Israel , September 2, 2015 /PRNewswire/ ... BLGTY, TASE: BOLT) ("BioLight" or the "Company"), a ... innovations in ophthalmology and cancer diagnostics, announced today ... treatment of glaucoma will be delivered at the ... of the European Society of Cataract & Refractive ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... members will be attending Pharma Ed Resources upcoming educational seminar and training ... industry leading speakers, this timely conference will provide Updates & Case Studies on ...
(Date:9/1/2015)... , September 2, 2015 ... auf die Forschung und Entwicklung neuartiger Therapien ... chronisch-entzündliche Darmerkrankungen und Reizdarm konzentriert, erhält vom ... dass sein neues Medikament patentiert wird. Das ... Allergien bei Kindern verhindert und Entzündungen vorbeugt.   ...
(Date:9/1/2015)... 1, 2015 Prostate cancer is ... American men. One in seven men will be ... cases are diagnosed annually. That said, not every ... powerful new technique, MRI Fusion Biopsy, to more ... treating only the affected areas and monitoring ...
Breaking Biology Technology:Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 3Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 2Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 3Das Patent von Swecure zur Verhinderung von Allergien bei Kindern wird in den USA zugelassen 2September Is Prostate Cancer Awareness Month 2September Is Prostate Cancer Awareness Month 3September Is Prostate Cancer Awareness Month 4
... CryoLife, Inc., (NYSE: CRY ) ... today announced,that it has received 510(k) clearance ... its CryoValve(R) SG pulmonary human heart valve ... proprietary,SynerGraft technology is designed to remove allogeneic ...
... CHENGDU, China, Feb. 7 /Xinhua-PRNewswire-FirstCall/ -- Tianyin,Pharmaceutical, Inc., ... modernized traditional Chinese medicine (TCM) based in Chengdu,China, ... of the Board of,Directors, will host a conference ... financial results., The conference call will take ...
... Feb 7 Dilon Technologies, makers of,a gamma imaging ... G. Moussa to the position of President and Chief ... in the medical device industry,having held a number of ... -- a health care corporation he ran as,CEO for ...
Cached Biology Technology:CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Pulmonary Heart Valves 2CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Pulmonary Heart Valves 3Tianyin Pharmaceutical, Inc. to Host 2008 Second Quarter Earnings Conference Call on Thursday, February 14, 2008 at 4:15 p.m. EST 2Newly Appointed Dilon Technologies President & CEO Robert G. Moussa Sees BSGI as ' ... Major Weapon in the Battle Against Cancer' 2
(Date:8/6/2015)... REDWOOD CITY, Calif. , Aug. 6, 2015 ... (D-Silicon Valley) will visit Crossmatch ™ to ... secure networks and protect data. Crossmatch is a ... solutions whose technologies and expertise are helping federal ... operational efficiency and security.   "The ...
(Date:8/5/2015)... 5, 2015 The biosensors market is proving ... penetration into newer sectors, and development of devices resulting ... space has seen the entry of multiple participants each ... (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) ... of the Global Biosensors Market ( http://www.frost.com/nee9 ), ...
(Date:7/31/2015)... de 2015 BGI llevará a cabo la 10ª ... al 25 de octubre de 2015, en ... su décimo aniversario este año. Desde su inauguración en ... reuniones anuales más influyentes del mundo en los campos ... científicas más dinámicas, entusiastas y amenas. ICG-10 ...
Breaking Biology News(10 mins):Rep. Honda to Visit Crossmatch in Redwood City 2Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3
... for a trial to investigate the safety of a ... Allergy and Infectious Diseases (NIAID), part of the National ... Rochester, NY, Baltimore and Los Angeles will enroll a ... part of the NIAID-sponsored Vaccine and Treatment Evaluation Units ...
... remains a challenging problem. Building classifiers based on ... the selection of non-redundant but relevant genes is ... enough to allow diagnosis even in regular clinical ... regulatory pathways. Here an entropy-based method is proposed ...
... rate of HIV infection, warn two senior doctors in an ... people worldwide, including over 2 million children, are now infected ... 2003. , The underlying reason for this continuing increase is ... write the authors. , For instance, the search for a ...
Cached Biology News:NIAID Initiates Trial of Experimental Avian Flu Vaccine 2
... loci identification through targeting resequencing. ... intensive assay validation/optimization, high throughput PCR ... customer-supplied samples and sequence alignment and ... rapid and highly accurate identification of ...
... Luciferase-based ENGENISTM (Entire Gene/cDNA or Isolated Sequence) ... a quantitative approach for evaluation of a ... as an efficient target for RNA interference ... are not perfect, leaving the probability of ...
... Stabilizer is a is a bovine protein-free ... product is an aqueous solution that contains ... buffered saline), pH 6.6 - 7.2. ... methylisothiazolone and 0.02% bromonitrodioxane as a preservative. ...
... Mouse anti-Yersinia pestis F1 antigen, ... Applications: ELISA: Use at ... at an assay dependent dilution. WB: ... Predicted molecular weight: 18 kDa. Not ...
Biology Products: